Transcription of PRODUCT MONOGRAPH
{{id}} {{{paragraph}}}
JANUVIA (sitagliptin tablets) Page 1 of 51 PRODUCT MONOGRAPH JANUVIA sitagliptin tablets 25, 50 and 100 mg sitagliptin (as sitagliptin phosphate monohydrate), tablets, oral ATC Code: A10BH01 Dipeptidyl peptidase 4 (DPP-4) inhibitors Merck Canada Inc. 16750 route Transcanadienne Kirkland, QC Canada H9H 4M7 Date of Revision: September 10, 2018 Submission Control No: 218647 JANUVIA (sitagliptin tablets) Page 2 of 51 Table of Contents PART I: HEALTH PROFESSIONAL INFORMATION .. 3 SUMMARY PRODUCT INFORMATION.
Response to all diabetic therapies should be monitored by periodic measurements of blood glucose and HbA1c levels, with a goal of decreasing these levels towards the normal range. HbA1c is especially useful for evaluating long-term glycemic control.1 Sitagliptin is substantially excreted by the kidney.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}